Author/Owner: Commissioning & Contracting Assistant Manager, Primary Care, SY ICB
Published Date: August 2019 (extended Feb-24 to Mar-24)
Date to Review: March 2024
Description: Shared care protocols for the Monitoring of Oral Disease Modifying Antirheumatic Drugs (DMARDs) Methotrexate (oral or subcutaneous), Leflunomide, Azathioprine, Mycophenolate Mofetil and Mercaptopurine & Monitoring of Disease Modifying Antirheumatic Drugs (DMARDs) (Gold Injections)